series-b
Stage
2018
Founded
2
Investors
About
Elephas Biosciences develops the elive™ platform, a live-tissue technology designed to predict immunotherapy response with unprecedented precision by analyzing cytokine activity in live tumor fragments.
Explore Elephas Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.